Active Recombinant Human CRELD2, His-tagged

• Cat.No.: CRELD2-336H
• Product Overview: Recombinant Human CRELD2 (Accession # AAH50675) Ala21-Leu353, fused with a C-terminal 6-His tag, was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Tag: His
• Predicted N Terminal: Ala21
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its ability to induce adhesion of ATDC5 mouse chondrogenic cells.The ED50 for this effect is typically 1-5 µg/mL.
• Molecular Mass: Recombinant Human CRELD2, His-tagged has a calculated MW of 36.7 kDa. In SDS-PAGE migrates as 55-60 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: CRELD2 cysteine-rich with EGF-like domains 2 [ Homo sapiens ]
• Official Symbol: CRELD2
• Synonyms: CRELD2; cysteine-rich with EGF-like domains 2; cysteine-rich with EGF-like domain protein 2; MGC11256; DKFZp667O055
• Gene ID: 79174
• mRNA Refseq: NM_001135101
• Protein Refseq: NP_001128573
• MIM: 607171
• UniProt ID: Q6UXH1
• Chromosome Location: 22q13.33